This public procurement record has 2 releases in its history.

Planning

16 Nov 2026 at 10:08

Planning

12 Nov 2026 at 13:51

Summary of the contracting process

Gloucestershire Hospitals NHS Foundation Trust is planning a managed pathology laboratory service covering Blood Sciences, Infection Sciences and Cellular Pathology. The package is expected to include analytical equipment, automation, point-of-care devices, software and middleware, reagents, consumables, managed inventory, maintenance, technical support, training, equipment replacement over its lifecycle and enabling works to prepare laboratory space. The Trust’s own staff will operate the equipment and report results; this is not an outsourced pathology service. Work is expected to begin at Gloucestershire Royal Hospital and Cheltenham General Hospital, then move to a new-build hub whose location has not been decided. Urgent laboratory provision will remain at one or both existing hospitals, with requirements depending on the hub location. The procurement is for laboratory services (CPV 71900000).

This is preliminary market engagement ahead of a planned competitive procurement; no tender invitation has been issued. The Trust is using written supplier feedback to shape its specification, performance measures, quality questions, evaluation approach, lot structure, phasing, commercial model and timetable. The working assumption is a lead Blood Sciences lot, including integration across the service, with separate lots for Infection Sciences and Cellular Pathology; the final structure and route to market remain under consideration. The expected contract term is 12 years, with two optional one-year extensions. The estimated value is £150 million excluding VAT (£180 million including VAT). The Trust expects to publish a future procurement notice on 1 February 2027. Suppliers taking part in engagement were asked to submit questionnaires and a conflict-of-interest declaration by 17:00 on 4 December 2026; this is an engagement response date, not a tender deadline.

The plans are relevant to suppliers able to provide and integrate complex clinical laboratory systems across multiple pathology disciplines, including specialist equipment, automation, middleware, reagents and consumables, as well as maintenance, support, training and laboratory installation works. The Trust is seeking market input on whether its draft specification and performance indicators are deliverable, and on quality questions, evaluation, commercial arrangements, phasing and the potential lot structure. This makes the engagement pertinent to lead managed-service providers, discipline specialists, equipment and software suppliers, and firms considering subcontracting or consortium bids. SMEs are explicitly considered suitable, and specialist providers and potential subcontractors or consortium members are invited to contribute. The two-phase service and unresolved hub location mean suppliers with experience designing resilient services across hospital and hub settings may be well placed to advise on workable models. No particular accreditation or capacity threshold is stated.

How relevant is this notice?

Notice Information

Notice Title

Pathology Managed Service - Preliminary Market Engagement

Notice Description

Gloucestershire Hospitals NHS Foundation Trust ("the Authority") is undertaking preliminary market engagement ahead of a competitive procurement for a Pathology Managed Service. The intended contract will provide, as a managed service, the laboratory equipment (analytical platforms, automation, point-of-care devices and associated instrumentation), reagents, consumables, maintenance, software/middleware, training and lifecycle replacement required to deliver the Authority's pathology service. The service is expected to be structured in two phases: Phase 1 covering the Authority's existing laboratories at Gloucestershire Royal Hospital and Cheltenham General Hospital, and Phase 2 following consolidation into a new-build pathology hub. The Authority's working direction is a new-build hub with the location not yet determined; two options remain under consideration, each with implications for the service model that suppliers should allow for: A hub on the Gloucester (hospital) site would require continued urgent haematology and clinical chemistry provision at Cheltenham General. An off-site hub would require acute (hot lab) provision and resilience at both Gloucestershire Royal and Cheltenham General. Transfusion provision should not be assumed at all three locations (remote issue, transport, storage, space and staffing remain dependencies); for microbiology, an off-site hub may require on-site blood-culture loading at the acute sites and further review of patient-facing sample collection and cryo/storage services. For cellular pathology, reliable frozen-section transport between sites would be essential. The disciplines in scope are Blood Sciences (clinical biochemistry, haematology, coagulation, immunology, transfusion-related equipment where included), Infection Sciences (microbiology, virology/molecular) and Cellular Pathology, together with enabling works to prepare laboratory space for installation. The Authority anticipates a lead provider for Blood Sciences with further lots or sub-lots for the other disciplines; the lot structure is a matter on which market feedback is sought. The Authority is seeking supplier feedback on the draft service specification, draft key performance indicators, the proposed lot structure and phasing, the commercial and pricing model, the evaluation approach and the proposed timetable, in order to finalise its procurement strategy and tender documents. Participation is open to all interested suppliers including SMEs, specialist providers and potential sub-contractors or consortium members.

Planning Information

Gloucestershire Hospitals NHS Foundation Trust (the Trust) is undertaking preliminary market engagement under sections 16 and 17 of the Procurement Act 2023 ahead of a planned procurement of a Pathology Managed Service. The Trust intends to procure a long-term managed service covering the equipment, automation, middleware, reagents, consumables, managed inventory, maintenance, support and training for its pathology laboratories. The Trust’s staff will continue to operate the equipment and report results; this is not an outsourcing of the pathology service. The service is expected to be delivered in two phases: Phase 1 at the existing laboratories at Gloucestershire Royal Hospital and Cheltenham General Hospital, and Phase 2 following a move to a hub laboratory, the location of which is yet to be confirmed, with urgent (Hot Lab) provision retained at one or both current sites. The indicative structure is three lots: Lot 1 Lead Managed Service (Blood Sciences, including the integrator role for the whole service), Lot 2 Infection Sciences and Lot 3 Cellular Pathology. The assumed term is 12 years with two optional one-year extensions. The lot structure, term and route to market are working assumptions and are subjects of this engagement. The purpose of the engagement is to test with the market the deliverability of the draft specification, the achievability of the draft key performance indicators, the clarity of the draft quality questions and proposed evaluation approach, and the proposed lot structure, phasing and commercial model, so that the final tender documents are well informed and capable of attracting competitive bids. No prices are sought. The engagement is a written exercise. Suppliers are invited to review an Information Pack and working drafts of the Consolidated Service Specification, Quality Questions and Scoring approach and KPI Schedule, and to return a Supplier Engagement Questionnaire. How to take part: register on the Trust’s e-procurement portal (Atamis, Health Family eCommercial System) and express interest in the engagement to access the documents. Completed questionnaires and a Conflict of Interest declaration must be submitted through the portal by 17:00 on 4 December 2026. Clarification questions must be raised through the portal messaging facility only; questions and answers will be anonymised and shared with all participants. Suppliers must not contact Trust staff or advisers directly. Participation is voluntary, at the supplier’s own cost, and is not a condition of taking part in any subsequent procurement. Responses are not evaluated or scored and confer no advantage. All material shared during the engagement will be made available with the tender documents so that suppliers who do not take part have the same information. Nothing in this notice commits the Trust to proceed with a procurement or to adopt any particular scope, lot structure, procedure or timetable.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-07ba95
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/108309-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME, VCSE
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

71 - Architectural, construction, engineering and inspection services


CPV Codes

71900000 - Laboratory services

Notice Value(s)

Tender Value
£150,000,000 £100M-£1B
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
16 Nov 2026Today
Submission Deadline
Not specified
Future Notice Date
1 Feb 20273 months to go
Award Date
Not specified
Contract Period
3 Jul 2028 - 3 Jul 2040 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Gloucestershire Hospitals NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
GLOUCESTER
Postcode
GL53 7AN
Postcode Area
Gloucester
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK7 Gloucestershire and Wiltshire
Small Region (ITL 3)
TLK73 Gloucestershire CC
Delivery Location
TLK13 Gloucestershire CC

Local Authority
Cheltenham
Electoral Ward
College
Westminster Constituency
Cheltenham

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...